Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
3.300
-0.011 (-0.33%)
At close: Jun 26, 2026, 4:00 PM EDT
3.260
-0.040 (-1.22%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Nuwellis Revenue
Nuwellis had revenue of $2.40M in the quarter ending March 31, 2026, with 26.21% growth. This brings the company's revenue in the last twelve months to $8.77M, down -0.20% year-over-year. In the year 2025, Nuwellis had annual revenue of $8.27M, down -5.38%.
Revenue (ttm)
$8.77M
Revenue Growth
-0.20%
P/S Ratio
0.03
Revenue / Employee
$230,763
Employees
38
Market Cap
277.39K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.27M | -470.00K | -5.38% |
| Dec 31, 2024 | 8.74M | -124.00K | -1.40% |
| Dec 31, 2023 | 8.86M | 321.00K | 3.76% |
| Dec 31, 2022 | 8.54M | 622.00K | 7.85% |
| Dec 31, 2021 | 7.92M | 480.00K | 6.45% |
| Dec 31, 2020 | 7.44M | 1.93M | 35.02% |
| Dec 31, 2019 | 5.51M | 513.00K | 10.26% |
| Dec 31, 2018 | 5.00M | 1.45M | 40.67% |
| Dec 31, 2017 | 3.55M | 2.26M | 175.64% |
| Dec 31, 2016 | 1.29M | 1.23M | 2,084.75% |
| Dec 31, 2015 | 59.00K | -236.00K | -80.00% |
| Dec 31, 2014 | 295.00K | 236.00K | 400.00% |
| Dec 31, 2013 | 59.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 407.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| INVO Fertility | 7.22M |
| Tenon Medical | 4.60M |
| Biomerica | 4.33M |
| Intelligent Bio Solutions | 3.91M |
| ENvue Medical | 2.18M |
| Catheter Precision | 1.11M |
| Profusa | 75.00K |
NUWE News
- 2 days ago - Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴) - GlobeNewsWire
- 2 days ago - Nuwellis Proxy statement: Proxy filing - Filings
- 2 days ago - Nuwellis Inc trading halted, news pending - TheFly
- 3 days ago - Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations - GlobeNewsWire
- 4 days ago - Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders - GlobeNewsWire
- 10 days ago - Nuwellis highlights clinical utility of its Aquadex SmartFlow system - TheFly
- 10 days ago - Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit - GlobeNewsWire
- 12 days ago - Nuwellis CEO transition to transition out of role, Mike McCormick to succeed - TheFly